Conflicts of interest:
Janel R. Long-Boyle has no conflict of interest to disclose.
Donald B. Kohn is a paid member of the Scientific Advisory Boards of
Allogene Therapeutics, Pluto Therapeutics,
ImmunoVec, and MyoGeneBio.
Ami J. Shah has no conflict of interest to disclose.
Sueli Marques Spencer is an employee and equity shareholder of Rocket
Pharmaceuticals, Inc.
Julián Sevilla receives honoraria and is a consultant and/or advisor for
the following: Amgen, Inc., Novartis Pharmaceuticals, Inc., Miltenyi
Biotech, Inc., Sobi, Inc., Rocket Pharmaceuticals, Inc. and has licensed
medicinal products from Rocket Pharmaceuticals, Inc.
Claire Booth Booth: SOBI: Consultancy, Honoraria; Orchard Therapeutics:
Consultancy, Honoraria; Takeda: Honoraria; Rocket Pharmaceuticals, Inc.:
Consultancy; GSK: Honoraria.
José Luis López Lorenzo has no conflict of interest to disclose.
Eileen Nicoletti is an employee and equity shareholder of Rocket
Pharmaceuticals, Inc.
Arpita Shah is an employee and equity shareholder of Rocket
Pharmaceuticals, Inc.
Meredith Reatz is an employee and equity shareholder of Rocket
Pharmaceuticals, Inc.
Joana Matos is an employee and equity shareholder of Rocket
Pharmaceuticals, Inc.
Jonathan D. Schwartz is an employee and equity shareholder of Rocket
Pharmaceuticals, Inc.